Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
about
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacySheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transitionThe therapeutic value of targeting inflammation in gastrointestinal cancersOmega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy.The meaning of PIWI proteins in cancer development.Prognostic significance of CD44 variant 2 upregulation in colorectal cancer.Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinomaEvaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.Sasa quelpaertensis Leaf Extract Inhibits Colon Cancer by Regulating Cancer Cell Stemness in Vitro and in Vivo.Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal CancerSmall-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner.Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatmentSignificance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguityMetformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells.Frontiers in Suicide Gene Therapy of Cancer.CD133: a cancer stem cells marker, is used in colorectal cancers.CD133: a stem cell biomarker and beyondThe Interaction between Cancer Stem Cell Marker CD133 and Src Protein Promotes Focal Adhesion Kinase (FAK) Phosphorylation and Cell Migration.Walnut Phenolic Extract and Its Bioactive Compounds Suppress Colon Cancer Cell Growth by Regulating Colon Cancer Stemness.EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.The low chamber pancreatic cancer cells had stem-like characteristics in modified transwell system: is it a novel method to identify and enrich cancer stem-like cells?Flow cytometry in cancer stem cell analysis and separation.CD133 as a target for colon cancer.Cell adhesion molecules and their relation to (cancer) cell stemness.Cancer stem cell detection and isolation.miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence.Cancer stem cells in human digestive tract malignancies.Isolation of colorectal cancer stem-like cells.Isolation and characterization of circulating tumor cells from human gastric cancer patients.Isolation, identification, and characterization of cancer stem cells: A review.Characterization of sphere-forming HCT116 clones by whole RNA sequencing.PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells.Time- and cell-resolved dynamics of redox-sensitive Nrf2, HIF and NF-κB activities in 3D spheroids enriched for cancer stem cells.Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis.The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal Adenocarcinoma.Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features.Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer.Increased PD-L1 expression in breast and colon cancer stem cells.p53 positively regulates the expression of cancer stem cell marker CD133 in HCT116 colon cancer cells.
P2860
Q26826863-9BDD2496-9577-458D-96D2-32568792BD5BQ26864979-FD9733C7-1582-4FA8-AA11-B5808EDF64CDQ27024203-C195FEF5-4AD6-40C2-93E6-BAF3B2D8BFE1Q31123584-53997301-87E7-4A4A-9B68-7D1F998FF5A7Q33685563-5DE3ED37-6AC3-471C-8598-58F2F28CFED9Q33918070-3A669B36-1360-44F8-97C2-A0732505AC24Q34486212-F22DDFA1-54CD-4571-AE45-E35E45FB92E3Q35156211-75A22842-152D-4D11-800C-F80CA3BC5317Q35723100-2EA9476F-C431-4105-AB62-C2E0F0D6AE8EQ35849680-B30D40BE-B478-4656-8A4F-BE175B644179Q35957393-30960BA2-C536-4290-B166-E07839EFE661Q35979751-0F580B96-502D-4530-84A2-9353EAC905A3Q36014411-077E1160-EB78-4292-B870-4B4495A70DCFQ36217557-36845F70-43AF-4250-B0E4-23F4038FE771Q36534930-40145C3E-3781-43A8-8EEA-62B50E20521DQ36819568-827FFE26-65E3-409B-B393-17EB63827AE6Q36982860-B9BD8DA2-F57D-4D1B-9010-B70DBE67F82EQ37117270-8362706C-C643-4EA0-AF4E-0C1B906557FCQ37133124-6809D63D-1378-4F69-A502-D1AC052C7EFBQ37520284-47BF666B-8759-47D1-9879-63236943459AQ37603012-0DA7E952-E36B-454C-9BAE-D9D673010C1DQ37981990-54B4D9CA-ED2E-47AE-884B-EAE5EC03AC03Q37990005-3D336F1D-0562-47D1-AE64-FF9FFDE000FAQ38188463-B06C03D1-3045-4234-A32D-8B0D5E8F43B9Q38234251-ED70C5A9-13C4-4AEC-9C49-0914869EEAF8Q38411340-656D7B7A-45DD-4D50-AD0C-A86493E65820Q38601789-16FE4849-8706-4E07-BE9C-E9EE3FBE408CQ38925989-0320E60E-7AFD-4137-BDF3-ABF54964FA6DQ38946865-9010EC15-0735-4014-B582-4D76A8F27F6DQ39055537-56D100CE-6233-4F13-AF2E-E82F2D1C6AB0Q40015136-46080A21-C5BC-413B-84C0-2843ECF07B8AQ40509393-D007B22C-C747-49E3-8075-12293CC0EE1FQ41975269-1B842E37-2F77-4813-8DD9-AB0BC79ACD98Q47444582-4CB002E1-E3DA-4A8B-8AC9-413B0F9453C3Q47620321-F82F1A57-ADBD-419D-8D48-DB3762B1B28EQ47624450-F6710EF6-D39F-42E5-80D1-C23F884F0EEEQ49517664-0982DD89-3176-4AAD-9789-F764DEF30370Q51178295-4AF5E13D-69D3-42F6-B304-7BDB613D94D4Q55439456-F60F4C9B-1FAF-43AE-8325-361F16C31279
P2860
Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Highly enriched CD133
@nl
Highly enriched CD133(+)CD44(+ ...... in HCT116 colon cancer cells.
@en
type
label
Highly enriched CD133
@nl
Highly enriched CD133(+)CD44(+ ...... in HCT116 colon cancer cells.
@en
prefLabel
Highly enriched CD133
@nl
Highly enriched CD133(+)CD44(+ ...... in HCT116 colon cancer cells.
@en
P2093
P2860
P1476
Highly enriched CD133(+)CD44(+ ...... in HCT116 colon cancer cells.
@en
P2093
Fang-wei Xie
Heng Jiang
Hou-jie Liang
Jian-fang Chen
Ke-li Chen
P2860
P2888
P304
P356
10.1007/S10585-011-9407-7
P577
2011-07-13T00:00:00Z